The popularity of copyright’s blockbuster initially drove a surge for the drug industry, but recent shifts present a murky scenario for shareholders. Generic competitors are eroding revenue, and ongoing legal battles https://haleemaippe433984.blogthisbiz.com/48881141/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-play